MidCap Financial

Founded 2008

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 33
Average round size
info
The average size of a deal this fund participated in
$56M
Portfolio companies 33
Rounds per year 2.54
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.03
Exits 19
Key employees Soon
Stages of investment
Debt
Post-Ipo

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
Summary

In 2008 was created MidCap Financial, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Bethesda.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the MidCap Financial, startups are often financed by New Leaf Venture Partners, Wellington Partners, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Silicon Valley Bank, Oxford Finance LLC, WuXi NextCODE. In the next rounds fund is usually obtained by Foresite Capital, CRG L.P., WuXi NextCODE.

The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Intarcia Therapeutics, Spectranetics, DNAnexus

The fund is generally included in 2-6 deals every year. Comparing to the other companies, this MidCap Financial performs on 30 percentage points more the average number of lead investments. Speaking about the real fund results, this Corporate Investor is 21 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014. Deals in the range of 50 - 100 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MidCap Financial:
Typical Co-investors
MidCap Financial is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MidCap Financial:
1 MTM

Funds with similar focus

Funds from United States, Bethesda
Funds with similar focus located in United States, Bethesda:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
The Still River Fund United States, Boston
Hyperplane Venture Capital United States, Boston
Graph Ventures United States, Palo Alto
Nirvana Digital Investment Holding Co Ltd -
Lough Shore Investments United Kingdom, Belfast
Beijing Wanxiang Shiba Media Investment Management China, Beijing
Sangam Ventures India, Chattarpur
Gravity Payments United States, Seattle
BuiltUp Ventures Israel, Tel Aviv
Roadzen United States, New York

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Unchained Labs

Biotechnology
Medical Device
Product Research
n/a
$155M10 Aug 2021 California United States

Xtant Medical

Health Care
Manufacturing
Medical
Medical Device
n/a
$20M06 May 2021 Montana United States

LendingPoint

E-Commerce
Finance
Financial Services
FinTech
Lending
n/a
$110M09 Mar 2021 Georgia United States

Medexus Pharma

Biotechnology
Medical Device
Pharmaceutical
n/a
$20M08 May 2020 Chicago Illinois United States

Digital Reasoning

Analytics
Artificial Intelligence
Big Data
Machine Learning
Natural Language Processing
Software
Text Analytics
1
$20M27 Jan 2020 Franklin Tennessee United States

Arboretum Investment Advisors, LLC.

Asset Management
Finance
1
$25M06 Dec 2019 New Hampshire Portsmouth United States

Protagonist Therapeutics

Biotechnology
Drug Discovery
Health Care
Medical
n/a
$50M31 Oct 2019 Australia Brisbane City Queensland

Sight Sciences

Eyewear
Health Care
Health Diagnostics
1
$31M04 Sep 2019 California United States

Gossamer Bio

Biotechnology
Health Care
Therapeutics
1
$150M02 May 2019 California San Diego United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MidCap Financial?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: